Dilworth IP Welcomes Dr. Cambria Alpha-Cobb to the Team
Dec 18th, 2014 by Thomas DeFelice | News | Recent News & Articles |
Dr. Cambria Alpha-Cobb has joined Dilworth IP’s Biotech and Pharmaceutical Practice Group as a Technology Specialist. Dr. Alpha-Cobb holds a Ph.D. in Molecular Biophysics and Biochemistry from Yale University where her research focused on bacterial resistance to antibiotics in addition to exploring small molecule signaling through the design of cell permeable drugs. Although her primary focus has been on advancements in the biological field, her research has broadly encompassed genetic engineering, protein and antibody design, and mycological studies. Cambria’s undergraduate work at Rice University included a study of the structural evolution of hemoglobin, while also majoring in Spanish language and culture. She speaks Spanish fluently and is also conversant in German.
Cambria further enhances Dilworth IP’s already high level of technical competency and is a great addition to our team. We look forward to working together with her!